FDA Approves First Agent for PSMA-PET Imaging in Prostate Cancer ...Middle East

Medscape - News
A new diagnostic agent, Gallium 68 PSMA-11, has been approved for institutional use in the PET imaging of PSMA-positive lesions in men with prostate cancer. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Agent for PSMA-PET Imaging in Prostate Cancer )

Apple Storegoogle play

Also on site :